Disc Medicine amends ATM agreement to increase potential offering from $59.7M to $200.0M

Disc Medicine, Inc.

As of Dec 5, 2023, only $7.2M of Initial $59.7M shares had been sold under original Oct 2023 ATM.
Amendment raises aggregate offering price to $200.0M, allowing additional share sales via Jefferies.
Prior prospectus sales terminated; new registration statement (S-3 File 333-275652) used for remaining shares.
Material terms unchanged; legal opinion from Goodwin Procter attached.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Disc Medicine, Inc. amended Open Market Sale Agreement with Jefferies LLC valued at Increase aggregate offering price from $59.7 million to $200.0 million (effective 2023-12-05).

Action: amendment
Agreement: atm program
Counterparty: Jefferies LLC
Value: Increase aggregate offering price from $59.7 million to $200.0 million
Effective: 2023-12-05

Exact text from the filing

On December 5, 2023, the Company and Jefferies entered into an amendment to the Agreement (the “Amendment”) to increase the aggregate offering price of the shares of common stock that the Company may offer under the Agreement from $59.7 million to $200.0 million (the “Additional Shares”).

View on SEC.gov

Browse all material agreements →

Disc Medicine, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-289224

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.